Table 1 Cox OS negative.
From: Comprehensive analysis of UPK3B as a marker for prognosis and immunity in pancreatic adenocarcinoma
Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
Pathologic T stage | 177 | 0.017 | |||
T1&T2 | 31 | Reference | Reference | ||
T3&T4 | 146 | 2.035 (1.079–3.838) | 0.028 | 1.193 (0.589–2.415) | 0.625 |
Pathologic N stage | 174 | 0.002 | |||
N0 | 50 | Reference | Reference | ||
N1 | 124 | 2.161 (1.287–3.627) | 0.004 | 2.171 (1.208–3.900) | 0.010 |
Pathologic M stage | 85 | 0.713 | |||
M0 | 80 | Reference | |||
M1 | 5 | 0.773 (0.185–3.227) | 0.724 | ||
Pathologic stage | 176 | 0.480 | |||
Stage I&Stage II | 168 | Reference | |||
Stage III&Stage IV | 8 | 0.676 (0.213–2.145) | 0.507 | ||
Histologic grade | 177 | 0.060 | |||
G1&G2 | 127 | Reference | Reference | ||
G3&G4 | 50 | 1.532 (0.993–2.363) | 0.054 | 1.420 (0.894–2.257) | 0.138 |
Anatomic neoplasm subdivision | 179 | 0.001 | |||
Head | 139 | Reference | Reference | ||
Body | 14 | 0.410 (0.165–1.016) | 0.054 | 0.575 (0.208–1.590) | 0.286 |
Tail | 15 | 0.733 (0.337–1.592) | 0.432 | 0.771 (0.336–1.770) | 0.540 |
Other | 11 | 0.104 (0.014–0.749) | 0.025 | 0.082 (0.011–0.625) | 0.016 |
History of diabetes | 147 | 0.776 | |||
No | 109 | Reference | |||
Yes | 38 | 0.923 (0.531–1.607) | 0.778 | ||
History of chronic pancreatitis | 142 | 0.685 | |||
No | 129 | Reference | |||
Yes | 13 | 1.169 (0.559–2.445) | 0.679 | ||
Alcohol history | 167 | 0.541 | |||
No | 65 | Reference | |||
Yes | 102 | 1.146 (0.739–1.779) | 0.543 | ||
UPK3B | 179 | 0.038 | |||
Low | 89 | Reference | Reference | ||
High | 90 | 1.542 (1.021–2.330) | 0.039 | 1.315 (0.854–2.025) | 0.213 |
